$2.45
0.031.24%
al cierre: -
$2.50
0.052.04%
After hour: Oct 31, 5:46 PM EDT
Comments
Loading...
Gossamer Bio Actividad de operaciones con información privilegiada
GOSSNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Gossamer Bio. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Gossamer Bio.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Gossamer Bio Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El agosto 20, 2025, Sandra Milligan, la empresa DIRECTOR purchased 26.05K acciones por $1.92 cada una.
Estadísticas de propiedad de Gossamer Bio Inc
Acciones en circulación
228.881M
Acciones en manos de personas con información privilegiada
1.629M
Porcentaje de acciones en manos de personas con información privilegiada
0.71%
Acciones en manos de instituciones
48.039M
Porcentaje de acciones en manos de instituciones
21.0%
Aug 20, 2025 | DIRECTOR | 26.05K | $1.92 | $50.02K | BUY | 81.41% | 58.05K | Aug 19 | ||
Jun 25, 2024 | CHIEF MEDICAL OFFICER | -1.91K | $0.66 | -$1.26K | SELL | -0.95% | 199.43K | Jun 24 | ||
Jun 24, 2024 | PRESIDENT & CEO | 372.00K | $0.67 | $250.28K | BUY | 7.21% | 5.53M | Jun 21 | ||
Jun 20, 2024 | COO/CFO | 100.00K | $0.59 | $59.11K | BUY | 26.32% | 480.01K | Jun 18 | ||
Jun 20, 2024 | CHIEF COMMERCIAL OFFICER | 25.00K | $0.60 | $15.05K | BUY | ∞ | 25.00K | Jun 17 | ||
Mar 28, 2024 | EVP, TECH OPS AND ADMIN | -6.43K | $1.16 | -$7.43K | SELL | -1.05% | 608.16K | Mar 27 | ||
Mar 28, 2024 | COO/CFO | -6.43K | $1.16 | -$7.43K | SELL | -1.34% | 472.75K | Mar 27 | ||
Mar 28, 2024 | PRESIDENT & CEO | -23.17K | $1.16 | -$26.77K | SELL | -0.45% | 5.16M | Mar 27 | ||
Mar 19, 2024 | CHIEF MEDICAL OFFICER | -4.02K | $1.33 | -$5.34K | SELL | -1.98% | 198.80K | Mar 18 | ||
Mar 19, 2024 | EVP, REGULATORY AFFAIRS | -4.02K | $1.33 | -$5.34K | SELL | -7.46% | 49.83K | Mar 18 | ||
Nov 17, 2023 | DIRECTOR | 32.00K | $0.79 | $25.21K | BUY | ∞ | 32.00K | Nov 15 | ||
Nov 14, 2023 | COO/CFO | 200.00K | $0.56 | $112.88K | BUY | 71.64% | 479.18K | Nov 13 | ||
Jun 26, 2023 | CHIEF MEDICAL OFFICER | -1.81K | $1.29 | -$2.34K | SELL | -0.90% | 200.11K | Jun 22 | ||
Apr 05, 2023 | COO/CFO | 55.00K | $1.02 | $56.09K | BUY | 32.32% | 225.16K | Apr 04 | ||
Mar 22, 2023 | EVP, TECH OPS AND ADMIN | 18.50K | $1.20 | $22.14K | BUY | 51.23% | 54.61K | Mar 20 | ||
Mar 22, 2023 | COO/CFO | 50.00K | $0.97 | $48.44K | BUY | 41.61% | 170.16K | Mar 20 | ||
Mar 22, 2023 | PRESIDENT & CEO | 878.57K | $1.14 | $1.00M | BUY | 23.36% | 4.64M | Mar 20 - Mar 22 | ||
Mar 20, 2023 | CHIEF SCIENTIFIC OFFICER | -6.03K | $1.10 | -$6.62K | SELL | -7.33% | 76.26K | Mar 16 | ||
Mar 20, 2023 | CHIEF MEDICAL OFFICER | -7.56K | $1.10 | -$8.30K | SELL | -3.61% | 201.93K | Mar 16 | ||
Mar 20, 2023 | EVP, REGULATORY AFFAIRS | -7.56K | $1.10 | -$8.31K | SELL | -12.32% | 53.85K | Mar 16 | ||
Oct 25, 2022 | EVP, REGULATORY AFFAIRS | -4.76K | $12.07 | -$57.43K | SELL | -7.19% | 61.41K | Oct 24 | ||
Oct 25, 2022 | CHIEF SCIENTIFIC OFFICER | -4.88K | $12.07 | -$58.87K | SELL | -5.59% | 82.29K | Oct 24 | ||
Oct 25, 2022 | CHIEF MEDICAL OFFICER | -4.76K | $12.07 | -$57.43K | SELL | -2.24% | 207.97K | Oct 24 | ||
Jul 15, 2022 | CHIEF SCIENTIFIC OFFICER | 6.93K | $7.21 | $49.99K | BUY | 8.64% | 87.17K | Jul 15 | ||
Jul 15, 2022 | EVP, TECH OPS AND ADMIN | 6.93K | $7.21 | $49.99K | BUY | 23.77% | 36.11K | Jul 15 | ||
Jul 15, 2022 | COO/CFO | 13.87K | $7.21 | $100.00K | BUY | 13.05% | 120.16K | Jul 15 | ||
Jul 15, 2022 | PRESIDENT & CEO | 138.70K | $7.21 | $1000.00K | BUY | 3.83% | 3.76M | Jul 15 | ||
Jul 05, 2022 | CHIEF SCIENTIFIC OFFICER | -8.81K | $8.25 | -$72.65K | SELL | -9.89% | 80.23K | Jul 01 | ||
Jun 23, 2022 | CHIEF MEDICAL OFFICER | -1.78K | $6.88 | -$12.23K | SELL | -0.83% | 212.44K | Jun 22 | ||
May 05, 2022 | CHIEF SCIENTIFIC OFFICER | -1.26K | $7.20 | -$9.09K | SELL | -1.40% | 89.04K | May 04 | ||
Mar 24, 2022 | EVP, TECH OPS AND ADMIN | -10.72K | $8.91 | -$95.59K | SELL | -1.75% | 601.23K | Mar 23 | ||
Mar 24, 2022 | PRESIDENT & CEO | -19.04K | $8.91 | -$169.70K | SELL | -0.52% | 3.62M | Mar 23 | ||
Mar 24, 2022 | COO/CFO | -10.72K | $8.91 | -$95.59K | SELL | -9.16% | 106.29K | Mar 23 | ||
Mar 17, 2022 | CHIEF SCIENTIFIC OFFICER | -5.00K | $8.28 | -$41.41K | SELL | -5.25% | 90.30K | Mar 16 | ||
Mar 17, 2022 | EVP, REGULATORY AFFAIRS | -6.28K | $8.28 | -$51.98K | SELL | -8.67% | 66.17K | Mar 16 | ||
Mar 17, 2022 | CHIEF MEDICAL OFFICER | -6.28K | $8.28 | -$51.98K | SELL | -2.85% | 214.21K | Mar 16 | ||
Oct 26, 2021 | EVP, REGULATORY AFFAIRS | -2.38K | $12.25 | -$29.12K | SELL | -3.18% | 72.45K | Oct 25 | ||
Oct 26, 2021 | CHIEF SCIENTIFIC OFFICER | -2.38K | $12.25 | -$29.12K | SELL | -2.43% | 95.31K | Oct 25 | ||
Oct 26, 2021 | CHIEF MEDICAL OFFICER | -2.38K | $12.25 | -$29.12K | SELL | -1.07% | 219.97K | Oct 25 | ||
Mar 25, 2021 | CHIEF SCIENTIFIC OFFICER | -5.49K | $9.48 | -$52.05K | SELL | -2.60% | 206.06K | Mar 23 | ||
Mar 25, 2021 | CHIEF FINANCIAL OFFICER | -5.49K | $9.48 | -$52.05K | SELL | -4.48% | 117.01K | Mar 23 | ||
Mar 25, 2021 | EVP & GENERAL COUNSEL | -5.49K | $9.48 | -$52.05K | SELL | -0.89% | 610.42K | Mar 23 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.